Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

Gabillard, Delphine; Lewden, Charlotte; Ndoye, Ibra; Moh, Raoul; Segeral, Olivier; Tonwe-Gold, Besigin; Etard, Jean-François; Pagnaroat, Men; Fournier-Nicolle, Isabelle; Eholié, Serge; Konate, Issouf; Minga, Albert; Mpoudi-Ngole, Eitel; Koulla-Shiro, Sinata; Zannou, Djimon Marcel; Anglaret, Xavier; Laurent, Christian

dc.contributor.author	Gabillard, Delphine
dc.contributor.author	Lewden, Charlotte
dc.contributor.author	Ndoye, Ibra
dc.contributor.author	Moh, Raoul
dc.contributor.author	Segeral, Olivier
dc.contributor.author	Tonwe-Gold, Besigin
dc.contributor.author	Etard, Jean-François
dc.contributor.author	Pagnaroat, Men
dc.contributor.author	Fournier-Nicolle, Isabelle
dc.contributor.author	Eholié, Serge
dc.contributor.author	Konate, Issouf
dc.contributor.author	Minga, Albert
dc.contributor.author	Mpoudi-Ngole, Eitel
dc.contributor.author	Koulla-Shiro, Sinata
dc.contributor.author	Zannou, Djimon Marcel
dc.contributor.author	Anglaret, Xavier
dc.contributor.author	Laurent, Christian
dc.date.accessioned	2014-11-30T16:11:39Z
dc.date.available	2014-11-30T16:11:39Z
dc.date.issued	2013-04-15
dc.identifier.citation	Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. 2013, 62 (5):555-61 J. Acquir. Immune Defic. Syndr.	en_GB
dc.identifier.issn	1944-7884
dc.identifier.pmid	23274931
dc.identifier.doi	10.1097/QAI.0b013e3182821821
dc.identifier.uri	http://hdl.handle.net/10144/336359
dc.description.abstract	In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.
dc.language.iso	en	en
dc.publisher	Lippincott Williams and Wilkins	en_GB
dc.rights	Archived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)	en_GB
dc.subject	HIV/AIDS	en_GB
dc.subject.mesh	Acquired Immunodeficiency Syndrome	en_GB
dc.subject.mesh	Adolescent	en_GB
dc.subject.mesh	Adult	en_GB
dc.subject.mesh	Africa South of the Sahara	en_GB
dc.subject.mesh	Anti-HIV Agents	en_GB
dc.subject.mesh	Asia	en_GB
dc.subject.mesh	CD4 Lymphocyte Count	en_GB
dc.subject.mesh	Cohort Studies	en_GB
dc.subject.mesh	Female	en_GB
dc.subject.mesh	HIV Infections	en_GB
dc.subject.mesh	HIV-1	en_GB
dc.subject.mesh	Humans	en_GB
dc.subject.mesh	Incidence	en_GB
dc.subject.mesh	Linear Models	en_GB
dc.subject.mesh	Male	en_GB
dc.subject.mesh	Young Adult	en_GB
dc.title	Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration	en
dc.identifier.journal	Journal of Acquired Immune Deficiency Syndromes (1999)	en_GB
refterms.dateFOA	2019-03-04T11:36:54Z
html.description.abstract	In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions.